What’s next for antitrust in 2021

Each quarter, the Hogan Lovells Antitrust and Competition team will address a timely antitrust topic explaining the key antitrust issues and practical implications for businesses. This...

Antitrust and tech: Key issues explained and explored

Each quarter, the Hogan Lovells Antitrust and Competition team will address a timely antitrust topic explaining the key antitrust issues and practical implications for...

Managing supply chain disruption in the life sciences and health care industry: Part 2 – Supply chain resilience and supply chain litigation/arbitration

We held the second webinar in the managing supply chain disruption in the Life Sciences sector webinar series on 25 June.

Managing supply chain disruption in the life sciences and health care industry: Part 1 – Supply chain risk management and immediate actions

The COVID-19 outbreak has produced an instant global economic shock that is – inevitably – affecting global supply chains.

Loading data